Differential actions of desipramine on sympathoadrenal release of noradrenaline and adrenaline.

16Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Spillovers noradrenaline (NA) and adrenaline (A) into plasma were examined before and after i.v. administration of 0.3‐0.5 mg kg‐1 desipramine (DMI) in 19 normal volunteers. DMI decreased the total body spillover of NA by 20 +/‐ 4%, but increased that of A by 45 +/‐ 10%. The results indicate differential sympathoadrenal actions of DMI, characterized by inhibition of NA release from sympathetic nerves and stimulation of A secretion from the adrenals. These effects of DMI provide an explanation for some of the cardiovascular complications of tricyclic antidepressant therapy and may also help to explain how sympathoadrenal function is differentially regulated. Copyright © 1995, Wiley Blackwell. All rights reserved

Cite

CITATION STYLE

APA

Eisenhofer, G., Friberg, P., Goldstein, D., & Esler, M. (1995). Differential actions of desipramine on sympathoadrenal release of noradrenaline and adrenaline. British Journal of Clinical Pharmacology, 40(3), 263–265. https://doi.org/10.1111/j.1365-2125.1995.tb05782.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free